Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.622, 2011-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Basiliximab confers significant clinical benefit for marginal cost
Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. :
Access to resources
Recommend
Basiliximab confers significant clinical benefit for marginal cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 399, 2003-01 ,pp. :
Prolonged enoxaparin sodium prophylaxis: significant benefit
Inpharma, Vol. 1, Iss. 1332, 2002-01 ,pp. :
Atopic dermatitis costs significant for US employers
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 525, 2007-01 ,pp. :